“APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases” has been published in the journal PLOS Medicine. This work was supported in part by JPND through the PERADES project, selected in the 2012 risk factors call.
Category Archives: JPND Publications
“New insights into the genetic etiology of Alzheimer’s disease and related dementias” has been published in the Journal of Nature Genetics. This work was supported in part by JPND through the EADB project.
“Brachial plexus magnetic resonance imaging differentiates between inflammatory neuropathies and does not predict disease course” has been published in the journal Brain and Behavior. This work was supported in part by JPND through the SOPHIA project, selected in the 2011 biomarkers call, the STRENGTH project, selected in the 2012 risk factors call and the ALSCare project, selected in the 2012 healthcare evaluation call.
“An aberrant phase transition of stress granule triggered by misfolded protein and prevented by chaperione function” has been published in The EMBO Journal. This work has been supported in part by JPND through the CureALS project, selected in the 2015 JPco-fuND call.
“Comparison of the adaptive implementation and evaluation of the Meeting Centers Support Program for people with dementia and their family careers in Europe; study protocol of the MEETINGDEM project” has been published in the journal BMC Geriatrics. This work has been supported in part by JPND through the MEETINGDEM project, selected in the 2012 healthcare evaluation call.
“Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis” has been published in the journal Science Translational Medicine. This work was supported in part by JPND through the STRENGTH project, selected in the 2012 risk factors call.
“Serum miRNAs miR-206, 143-3p and 374b-5p as potential biomarkers for amyotrophic lateral sclerosis (ALS)” has been published in the journal Neurobiology of Aging. This work has been supported in part by JPND through the STRENGTH project, selected in the 2012 risk factors call.
“The effects of an extensive programme on the progression of Mild Cognitive Impairment (MCI): study protocol for a randomized controlled trial” has been published in the journal BMC Geriatrics. This work was supported by JPND through the NeuroExercise project, selected in the 2013 preventive strategies call.
“Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score” has been published in the journal PLOS Medicine. This work was supported in part by JPND through the APGeM project, selected in the 2012 risk factors call.
“Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease” has been published in the journal Molecular Neurobiology. This work was supported in part by JPND through the DEMTEST project, selected in the 2011 biomarkers call.
“The Alzheimer’s disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway” has been published in the Journal of Neuroinflammation. This work was supported in part by JPND through the APGeM project, selected in the 2012 risk factors call.